Relationship of B-type natriuretic peptide and anemia in patients with and without heart failure: A substudy from the Breathing Not Properly (BNP) Multinational Study

American Journal of Hematology

Volumn 80, Issue 3, 2005, Pages 174-180

  Wu, Alan H B ^a   Omland, Torbjørn ^b   Knudsen, Cathrine Wold ^c   McCord, James ^d   Nowak, Richard M ^d   Hollander, Judd E ^e   Duc, Philippe ^f   Storrow, Alan B ^g   Abraham, William T ^h   Clopton, Paul ⁱ   Maisel, Alan S ⁱ   McCullough, Peter A ^j  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d HENRY FORD HOSPITAL   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f BICHAT HOSPITAL   (France)

^g UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF KENTUCKY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j WILLIAM BEAUMONT HOSPITAL   (United States)

more..

Author keywords

Anemia; B type natriuretic peptide; Body mass index; Estimated glomerular filtration rate; Heart failure; Hemoglobin

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ANEMIA; ARTICLE; BODY MASS; BREATHING; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; EMERGENCY WARD; FEMALE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 27644514330     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20456     Document Type: Article

References (24)

1. Toto RD. Anemia of chronic disease: past, present, and future. Kidney Int Suppl 2003(Nov);(87):S20-23.
2. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:178-186.
3. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure. The Prospective Randomized Amlodipine Survival Evaluation (PRAISE). J Am Coll Cardiol 2003;41: 1933-1939.
4. Anand I, McMurray JJV, Whitmore J, el al. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004;110:149-154.
5. Kosiborod M, Smith L, Radford MJ, Foody JM, Krumholz HM. The prognostic importance of anemia in patients with heart failure. Am J Med 2003;114:112-119.
6. Szachniewicz J, Petruk-Kowalczyk J, Majda J, et al. Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol 2003;90:303-308.
7. Hunt SA, Baker DW, Chin MH, et al. 2001. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Bethesda, MD: American College of Cardiology and American Heart Association, Inc. http://www.acc.org/clinical/guidelines/failure/hf_index. htm (page last updated 03/12/2002).
8. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-1560.
9. Linde T, Wikstrom B, Andresson LG, Danilson BG. Renal anaemia treatment with recombinant human erythropoietin increases cardiac output in patients with ischaemic heart disease. Scand J Urol Nephrol 1996;30:115-120.
10. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167.
11. th edition. Boston: Little, Brown and Co.; 1994. p 253-259.
12. Wieczorek SJ, Wu AHB, Christenson R, et al. A rapid B-type natriuretic peptide (BNP) assay accurately diagnoses left ventricular dysfunction and heart failure-a multi-center evaluation. Am Heart J 2002;144:834-839.
13. Nutritional anaemias. Report of a WHO scientific group. World Health Org Tech Rep Ser 1968;405:5-37.
14. McCullough PA, Due P, Omland T, et al. B-Type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 2003,41:571-579.
15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
16. Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIM1 18. J Am Coll Cardiol 2003;41:1264-1272.
17. Wang TJ, Larson MG, Levy D, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004;109:594-600.
18. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976-982.
19. Willis MS, Lee ES, Grenache DG. Effect of anemia on plasma concentrations of NT-proBNP. Clin Chim Acta 2005;358:175-181.
20. Brucks S, Little WC, Chao T, et al. Relation of anemia to diastolic heart failure and the effect on outcome. Am J Cardiol 2004;93:1055-1057.
21. Wu AHB, Smith AC, Mather JF, el al. Biological variation for NT-pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003,92:428-431.
22. Dahlstrom U. Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail 2004;6:281-287.
23. Talwar S, Siebenhofer A, Williams B, Ng LL. Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N-terminal proBNP. Heart 200;83:278-282.
24. Androne AS. Katz SD. Lund L, et al. Hemodilution is common in patients with advanced heart failure. Circulation 2003;107: 226-229.